Anyone have additional DD on $RVVTF (Revive Therapeutics) repurposing of Bucillamine (anti-rheumatic) for COVID treatment?
by Baron | March 22, 2022 10:55 am
Hi folks. Disclaimer, I currently have a position in $RVVTF but I’m looking to bolster my research before perhaps taking a larger position. I know the FDA[1] let Revive SKIP Phase II and go straight to Phase III trials but I’m not well-versed in the science behind this. I rely on folks in the biotech field and would appreciate someone like Doc Gumshoe or the sleuths here on GumShoe to kick the tires, weigh in…
Thanks in advance.
Baron
https://www.nasdaq.com/articles/revive-gets-clearance-in-turkey-to-proceed-with-phase-3-trial-for-bucillamine-in-covid-19
Revive Therapeutics – DD Compendium (updated)[2] from RVVTF[3]
- FDA: https://www.stockgumshoe.com/tag/fda/
- Revive Therapeutics – DD Compendium (updated): https://www.reddit.com/r/RVVTF/comments/sypzcr/revive_therapeutics_dd_compendium_updated/?ref_source=embed&ref=share
- RVVTF: https://www.reddit.com/r/RVVTF/
Source URL: https://www.stockgumshoe.com/2022/03/microblog-anyone-have-additional-dd-on-rvvtf-revive-therapeutics-repurposing-of-bucillamine-anti-rheumatic-for-covid-treatment/
Leave a Reply